Table 3.
Hormonal Status
Patient | Age (years) | Mutation | Hormonal levels | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Basal FSH IU/L [1.5-12] |
FSH at the peak (after GnRH stimulation) [1.5–2 × basal] |
Basal LH IUI/L [1.5-8.5] |
LH at the peak (after GnRH stimulation) [3-4 × basal] |
Basal total testosterone nmol/L [10.4-41.6] |
Testosterone/LH (nMol / IU) | PRL mIU/L [86-324] |
Leptin (µg/L) | |||
1 | 22 | BBS1: c.[479G>A];[479G>A], p.[Arg160Gln];[Arg160Gln] | 2.42 | 4.65 | 4.71 | 29.3 | 16.3 | 3.46 | 239 | 21.2 |
2 | 25 | BBS1: c.[1169T>G];[1169T>G], p.[Met390Arg];[Met390Arg] | 2.67 | 5.02 | 2.94 | 20.8 | not performed | not performed | 8.83 | |
3 | 24 | BBS1: c.[1169T>G];[1169T>G], p.[Met390Arg];[Met390Arg] | 5.37 | 7.15 | 3.21 | 15.7 | 17.7 | 5.51 | 176 | not performed |
4 | 36 | BBS1: c.[382C>T];[382C>T], p.[Gln128*];[Gln128*] |
not performed | not performed | not performed | not performed | not performed | not performed | not performed | |
5 | 24 | BBS5: c.[413G>C];[413G>C], p.[Arg138Pro];[Arg138Pro] | 3.26 | 5.94 | 3.64 | 20.6 | 13.8 | 3.79 | 134 | 12.6 |
6 | 35 | BBS10: c.[271dup];[963T>G], p.[Cys91Leufs*5];[Tyr321*] | 2.08 | 3.69 | 3.38 | 12.5 | 12.8 | 3.77 | 106 | not performed |
7 | 38 | BBS1: c.[1169T>G]; [1214_1215ins[MT113356], p.[Met390Arg];[Ala406Glnfs*47]. | 3.51 | 6.37 | 4.11 | 26.9 | 11.1 | 2.70 | 94.7 | 4.78 |
8* | 22 | BBS1: c.[1169T>G];[1169T>G], p.[Met390Arg];[Met390Arg] | 0.85 | not performed | 0.71 | not performed | 18.7* | Not applicable | 295 | 19.8 |
9 | 26 | BBS9: c.[703-?_886+?del];[832C>T], p.[Val235Phefs*6];[Arg278*] |
1.56 | 3.16 | 1.66 | 12 | 6.9 | 4.15 | normal | 50.4 |
10 | 18 | BBS3: c.[535G>A];[535G>A], p.[Asp179Asn];[Asp179Asn] |
2.84 | 8.46 | 3.57 | 51.8 | 8.6 | 2.4 | 72.1 | not performed |
11 | 39 | BBS12: c.[1037T>C];[1037T>C], p.[Ile346Thr];[Ile346Thr] | 9.41 | 20.5 | 7.02 | 43 | 11.1 | 1.58 | 209 | not performed |
*Patient 8 undergoing testosterone therapy